1245-00-7|Sitsirikin - Shanghai Canbi Pharma Ltd.

Current Location
Home Products
detail

Sitsirikin | CAS:1245-00-7

Sitsirikin

Name：Sitsirikin
CAS：1245-00-7
Synonyms：(16R)-18,19-Didehydro-17-hydroxy-17,18-secoyohimban-16-carboxylic acid methyl ester
Molecular Formula：C₂₁H₂₆N₂O₃
Molecular Weight：354.44
EINESC：

Description

Properties

Melting point	239-241 ºC (分解)**
Density	1.25±0.1 g/cm3 (20 ºC

Safety

没有数据	没有数据

SDS

Source	SDS/MSDS Samples
没有数据	没有数据

Synthetic Route

Name	CAS

Articles

Peer-Reviewed Papers

Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2--a global assessment based on bibliographic sources.Michael Heinrich et al.Journal of ethnopharmacology, 125(1), 108-144 (2009-06-10) Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.Heinz H Schmeiser et al.International journal of cancer, 135(2), 502-507 (2014-06-13) Increased expression of p21WAF1/CIP1 in kidney proximal tubules mediates fibrosis.Judit Megyesi et al.American journal of physiology. Renal physiology, 308(2), F122-F130 (2014-11-28) [Advances in studies on pharmacokinetics of aristolochic acid I].Guan Wang et al.Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 31(19), 1573-1575 (2006-12-15) A Balkan riddle's serendipitous solution.Jon Cohen Science (New York, N.Y.), 344(6180), 146-146 (2014-04-12) Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway.Juan Wu et al.Toxicology, 318, 22-31 (2014-02-18)

Remarks

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

Name	CAS

Description

Properties

Safety

SDS

Related Products

Related News